PTC Therapeutics Inc., of South Plainfield, N.J., said it formed a collaboration with Aldevron LLC, of Fargo, N.D., to secure GMP manufacturing capacity for its gene therapy portfolio, including Friedreich ataxia and Angelman syndrome programs in its gene therapy pipeline. Financial terms were not disclosed.